| Puget Sound Home Health | |
| 3906 South 74th Street, Ste 101, Tacoma, Washington 98409 | |
| (253) 581-9410 | |
| Name | Puget Sound Home Health |
|---|---|
| Location | 3906 South 74th Street, Ste 101, Tacoma, Washington |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 507101 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 98001, 98002, 98022, 98321, 98323, 98327, 98328, 98329, 98332, 98333, 98335, 98338, 98349, 98351, 98354, 98360, 98371, 98372, 98373, 98374, 98375, 98387, 98388, 98390, 98391, 98394, 98402, 98403, 98404, 98405, 98406, 98407, 98408, 98409, 98418, 98421, 98422, 98424, 98433, 98439, 98443, 98444, 98445, 98446, 98465, 98466, 98467, 98498, 98499, 98580 |
| NPI Number | 1265476881 |
| Organization Name | PUGET SOUND HOME HEALTH LLC |
| Address | 7714 Bridgeport Way W, Lakewood, WA 98499 |
| Phone Number | 253-581-9410 |
News Archive
According to a new research report, the extremely high prevalence of diabetes and obesity in the Gulf nation of Kuwait might be linked to the very high levels of uranium in these individuals. This in turn could be associated with the large amounts of depleted uranium dumped here in the form of US munitions during the Gulf war of 1990-91.
In the June issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD), researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.
In an opinion article published in this week's theme edition of the Journal of the American Medical Association focusing on comparative effectiveness research, a team of Johns Hopkins University bioethicists argues forcefully for streamlining federal restrictions on at least some low-risk clinical comparative effectiveness research, instead of easing them - as is now proposed - solely for low-risk social and behavior research involving surveys, interviews and focus groups.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
› Verified 8 days ago
| NPI Number | 1912242678 |
| Organization Name | SYMBOL HEALTHCARE, INC. |
| Doing Business As | PUGET SOUND HOME HEALTH |
| Address | 4002 Tacoma Mall Blvd Ste 204, Tacoma, WA 98409 |
| Phone Number | 253-581-9410 |
News Archive
According to a new research report, the extremely high prevalence of diabetes and obesity in the Gulf nation of Kuwait might be linked to the very high levels of uranium in these individuals. This in turn could be associated with the large amounts of depleted uranium dumped here in the form of US munitions during the Gulf war of 1990-91.
In the June issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD), researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.
In an opinion article published in this week's theme edition of the Journal of the American Medical Association focusing on comparative effectiveness research, a team of Johns Hopkins University bioethicists argues forcefully for streamlining federal restrictions on at least some low-risk clinical comparative effectiveness research, instead of easing them - as is now proposed - solely for low-risk social and behavior research involving surveys, interviews and focus groups.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
› Verified 8 days ago
| Quality Rating: |
News Archive
According to a new research report, the extremely high prevalence of diabetes and obesity in the Gulf nation of Kuwait might be linked to the very high levels of uranium in these individuals. This in turn could be associated with the large amounts of depleted uranium dumped here in the form of US munitions during the Gulf war of 1990-91.
In the June issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD), researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.
In an opinion article published in this week's theme edition of the Journal of the American Medical Association focusing on comparative effectiveness research, a team of Johns Hopkins University bioethicists argues forcefully for streamlining federal restrictions on at least some low-risk clinical comparative effectiveness research, instead of easing them - as is now proposed - solely for low-risk social and behavior research involving surveys, interviews and focus groups.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 100 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.6 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.8 | 99.6 |
| How often the home health team checked patients for depression | 96.6 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 79.4 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 87.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.3 | 96.4 |
News Archive
According to a new research report, the extremely high prevalence of diabetes and obesity in the Gulf nation of Kuwait might be linked to the very high levels of uranium in these individuals. This in turn could be associated with the large amounts of depleted uranium dumped here in the form of US munitions during the Gulf war of 1990-91.
In the June issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD), researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.
In an opinion article published in this week's theme edition of the Journal of the American Medical Association focusing on comparative effectiveness research, a team of Johns Hopkins University bioethicists argues forcefully for streamlining federal restrictions on at least some low-risk clinical comparative effectiveness research, instead of easing them - as is now proposed - solely for low-risk social and behavior research involving surveys, interviews and focus groups.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 83.2 | 79.6 |
| How often patients got better at getting in and out of bed | 84.5 | 81.1 |
| How often patients got better at bathing | 86.6 | 82.3 |
| How often patients’ breathing improved | 85.5 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 95.7 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 74.9 | 75 |
| How often home health patients had to be admitted to the hospital | 15.8 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 11.9 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 92.1 | 94 |
News Archive
According to a new research report, the extremely high prevalence of diabetes and obesity in the Gulf nation of Kuwait might be linked to the very high levels of uranium in these individuals. This in turn could be associated with the large amounts of depleted uranium dumped here in the form of US munitions during the Gulf war of 1990-91.
In the June issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD), researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.
In an opinion article published in this week's theme edition of the Journal of the American Medical Association focusing on comparative effectiveness research, a team of Johns Hopkins University bioethicists argues forcefully for streamlining federal restrictions on at least some low-risk clinical comparative effectiveness research, instead of easing them - as is now proposed - solely for low-risk social and behavior research involving surveys, interviews and focus groups.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
› Verified 8 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
According to a new research report, the extremely high prevalence of diabetes and obesity in the Gulf nation of Kuwait might be linked to the very high levels of uranium in these individuals. This in turn could be associated with the large amounts of depleted uranium dumped here in the form of US munitions during the Gulf war of 1990-91.
In the June issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD), researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.
In an opinion article published in this week's theme edition of the Journal of the American Medical Association focusing on comparative effectiveness research, a team of Johns Hopkins University bioethicists argues forcefully for streamlining federal restrictions on at least some low-risk clinical comparative effectiveness research, instead of easing them - as is now proposed - solely for low-risk social and behavior research involving surveys, interviews and focus groups.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
› Verified 8 days ago
The patient survey data of Puget Sound Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 84 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 81 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 81 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 80 | 78 |
News Archive
According to a new research report, the extremely high prevalence of diabetes and obesity in the Gulf nation of Kuwait might be linked to the very high levels of uranium in these individuals. This in turn could be associated with the large amounts of depleted uranium dumped here in the form of US munitions during the Gulf war of 1990-91.
In the June issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD), researchers report their findings from the first-ever study examining the prognostic value of serum HBV DNA levels for patients with liver cancer undergoing chemotherapy.
In an opinion article published in this week's theme edition of the Journal of the American Medical Association focusing on comparative effectiveness research, a team of Johns Hopkins University bioethicists argues forcefully for streamlining federal restrictions on at least some low-risk clinical comparative effectiveness research, instead of easing them - as is now proposed - solely for low-risk social and behavior research involving surveys, interviews and focus groups.
In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
› Verified 8 days ago
Kindred At Home Location: 4020 S 56th St, Ste 101, Tacoma, Washington 98409 Ratings: Phone: (253) 475-6862 | |
Multicare Good Samaritan Home Health Location: 3901 South Fife Street, Tacoma, Washington 98409 Ratings: Phone: (253) 301-6400 | |
Puget Sound Home Health Location: 3906 South 74th Street, Ste 101, Tacoma, Washington 98409 Ratings: Phone: (253) 581-9410 | |
Emerald Healthcare Inc Location: 4002 Tacoma Mall Blvd, Ste 204a, Tacoma, Washington 98409 Ratings: Phone: (253) 735-4282 | |
Envision Home Health Location: 1818 S Union Ave Ste 1a, Tacoma, Washington 98405 Ratings: Phone: (206) 452-0058 |